Obtucarbamate BCAS# 20913-18-2 |
Quality Control & MSDS
Number of papers citing our products
Chemical structure
3D structure
Cas No. | 20913-18-2 | SDF | Download SDF |
PubChem ID | 11064442 | Appearance | Powder |
Formula | C11H14N2O4 | M.Wt | 238.2 |
Type of Compound | Alkaloids | Storage | Desiccate at -20°C |
Solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | ||
Chemical Name | methyl N-[3-(methoxycarbonylamino)-2-methylphenyl]carbamate | ||
SMILES | CC1=C(C=CC=C1NC(=O)OC)NC(=O)OC | ||
Standard InChIKey | JNNLWOJZIPJIQG-UHFFFAOYSA-N | ||
Standard InChI | InChI=1S/C11H14N2O4/c1-7-8(12-10(14)16-2)5-4-6-9(7)13-11(15)17-3/h4-6H,1-3H3,(H,12,14)(H,13,15) | ||
General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. |
Description | 1. Obtucarbamate B has antitussive activity. |
Obtucarbamate B Dilution Calculator
Obtucarbamate B Molarity Calculator
1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
1 mM | 4.1982 mL | 20.9908 mL | 41.9815 mL | 83.9631 mL | 104.9538 mL |
5 mM | 0.8396 mL | 4.1982 mL | 8.3963 mL | 16.7926 mL | 20.9908 mL |
10 mM | 0.4198 mL | 2.0991 mL | 4.1982 mL | 8.3963 mL | 10.4954 mL |
50 mM | 0.084 mL | 0.4198 mL | 0.8396 mL | 1.6793 mL | 2.0991 mL |
100 mM | 0.042 mL | 0.2099 mL | 0.4198 mL | 0.8396 mL | 1.0495 mL |
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. |
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- Mangochinine
Catalog No.:BCN4913
CAS No.:209115-67-3
- JWH 073
Catalog No.:BCC1674
CAS No.:208987-48-8
- Swertianin
Catalog No.:BCC8258
CAS No.:20882-75-1
- Testosterone benzoate
Catalog No.:BCC9166
CAS No.:2088-71-3
- Saikosaponin D
Catalog No.:BCN1088
CAS No.:20874-52-6
- (1R,1'S,3'R/1R,1'R,3'S)-L-054,264
Catalog No.:BCC7364
CAS No.:208706-12-1
- Ermanin
Catalog No.:BCN4912
CAS No.:20869-95-8
- Boc-His(Boc)-OH
Catalog No.:BCC3399
CAS No.:20866-46-0
- Berberine
Catalog No.:BCN4911
CAS No.:2086-83-1
- Primulic Acid 2
Catalog No.:BCC8237
CAS No.:208599-88-6
- H-Tle-OH
Catalog No.:BCC2659
CAS No.:20859-02-3
- Micafungin sodium
Catalog No.:BCC1750
CAS No.:208538-73-2
- Entecavir Hydrate
Catalog No.:BCC1109
CAS No.:209216-23-9
- Fmoc- ß-HoAsp(OtBu)-OH
Catalog No.:BCC3230
CAS No.:209252-17-5
- Neocryptomerin
Catalog No.:BCN8023
CAS No.:20931-36-6
- Beta-mangostin
Catalog No.:BCN1213
CAS No.:20931-37-7
- Platycoside A
Catalog No.:BCN3241
CAS No.:209404-00-2
- VX-745
Catalog No.:BCC3966
CAS No.:209410-46-8
- 1-(2-Amino-5-chlorophenyl)-1-(trifluoromethyl)-3-cyclopropyl-2-propyn-1-ol
Catalog No.:BCC8404
CAS No.:209414-27-7
- SB271046
Catalog No.:BCC5057
CAS No.:209481-20-9
- SB 271046 hydrochloride
Catalog No.:BCC1924
CAS No.:209481-24-3
- Isotanshinone IIA
Catalog No.:BCN2501
CAS No.:20958-15-0
- Isotanshinone I
Catalog No.:BCN2500
CAS No.:20958-17-2
- Dihydroisotanshinone I
Catalog No.:BCN2308
CAS No.:20958-18-3
[Antitussive constituents of Disporum cantoniense].[Pubmed:24791497]
Zhongguo Zhong Yao Za Zhi. 2013 Dec;38(23):4099-103.
The antitussive activity assay for the root extraction of Disporum cantoniense was carried out with coughing mice induced by ammonia liquor. The results showed that the ethanol and water extractions of D. cantoniense possess strong antitussive activity, and the high dose of the former was better than positive control, and then the constituents of the ethanol extraction were separated and purified by various modern chromatographic techniques. Their structures were identified by physico-chemical properties and spectroscopic data. As a result, eight compounds were isolated and identified as stigmast-4-en-3-one(1), (22E, 24R)-ergosta-5, 7, 22-trien-3beta-ol(2), obtucarbamate A(3), Obtucarbamate B(4), neotigogenin(5), azo-2, 2'-bis[Z-(2,3-dihydroxy-4-methyl-5-methoxy) phenyl ethylene] (6),dimethyl {[carbonylbis (azanediyl)] bis( 2-methyl-5, 1-phenylene) j dicarbamate (7) , and quercetin-3-O-pB-D-glucopyranoside(8). All compounds were isolated from this plant for the first time, and the result of bioactivity-directed isolation showed that compounds 3, 4, and 6 had obvious effect on antitussive activity, and compound 6 had the same level as positive control.